Background: Weight loss has been shown effective in the treatment of the obstructive sleep apnea-hypopnea syndrome. Regrettably, many obese patients are unable to achieve sustained and useful weight loss by dietary means. Recently, bariatric surgery has emerged as an alternative to treat obesity and many of its comorbidities, although its role for sleep apnea treatment is still not defined. Objectives: To evaluate the impact of bariatric surgery on obstructive sleep apnea in morbidly obese patients. Methods: In this cohort study, polysomnography, Epworth Sleepiness Scale questionnaire and clinical assessment were performed in 12 of 13 morbidly obese patients with moderate to severe obstructive sleep apnea treated with bariatric surgery through Roux-en-Y gastric bypass procedure after a minimum of 18 months post surgery. Results: The mean (±SD) loss of excess body weight was 70.5 ± 24%. The mean level obtained in the Epworth Scale was 4.8. There was a significant reduction in the apnea-hypopnea index, from a median of 46.5 (range: 33–140) to 16 (range: 0.9–87) events per hour (p < 0.05), an improvement in mean oxygen saturation from 85.7 ± 5.1 to 94.5 ± 3.6% (p < 0.05) and in minimum oxygen saturation from 64.7 ± 13.4 to 78.7 ± 13.7% (p < 0.05). The magnitude of the weight loss and the improvements in mean and minimum oxygen saturation were positively correlated, (r = 0.76; p ≤ 0.05, and r = 0.59; p ≤ 0.05, respectively). Conclusions: Weight loss achieved by bariatric surgery is associated with significant long-term improvements in obstructive respiratory event, oxygenation and resolution of daytime somnolence.

1.
Caples SM, Gami AS, Somers IK: Obstructive sleep apnea. Ann Intern Med 2005;142:187–197.
2.
Malhotra A, White DP: Obstructive sleep apnoea. Lancet 2002;360:237–245.
3.
Strollo PJ, Rogers RM: Current concepts: obstructive sleep apnea. N Engl J Med 1996;334:99–104.
4.
Dixon JB, Schachter LM, O’Brien AE: Predicting sleep apnea and excessive day sleepiness in the severely obese – indicators for polysomnography. Chest 2003;123:1134–1141.
5.
O’Keeffe T, Patterson EJ: Evidence supporting routine polysomnography before bariatric surgery. Obes Surg 2004;14:23–26.
6.
Frey WC, Pilcher J: Obstructive sleep-related breathing disorders in patients evaluated for bariatric surgery. Obes Surg 2003;13:676–683.
7.
Ulukavak Ciftci TU, Kokturk O, Bukan N, Bilgihan A: Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome. Respiration 2005;72:395–401.
8.
Smith PL, Hudgel DW, Olson LG: Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndrome. Am J Respir Crit Care Med 1994;150:1738–1745.
9.
Flemons WW, Douglas NJ, Kuna ST, Rodenstein DO, Wheatley J: Access to diagnosis and treatment of patients with suspected sleep apnea. Am J Respir Crit Care Med 2004;169:668–672.
10.
Zozula R, Rosen R: Compliance with continuous positive airway pressure therapy: assessing and improving treatment outcomes. Curr Opin Pulm Med 2001;7:391–398.
11.
Peppard PE, Young T, Palta M, Dempsey J, Skatrud J: Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000;284:3015–3021.
12.
National Business Group on Health: Obesity in adults. http://www.businessgrouphealth.org/services/obesity.cfm (accessed October 5, 2005).
13.
National Task Force on the Prevention and Treatment of Obesity. Very low-calorie diets. JAMA 1993;270:967–974.
14.
Cabral MD: Tratamento clínico da obesidade mórbida; in Garrido AB Jr: Cirurgia da obesidade. São Paulo, Atheneu, 2002, pp 35–44.
15.
Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K: Bariatric surgery – a systematic review and meta-analysis. JAMA 2004;292:1724–1737.
16.
Frigg A, Peterli R, Peters T, Ackermann C, Tondelli P: Reduction in co-morbidities 4 years after laparoscopic adjustable gastric banding. Obes Surg 2004;14:216–223.
17.
Simard B, Turcotte H, Marceau P, Biron S, Hould FS, Lebel S, Marceau S, Boulet LP: Asthma and sleep apnea in patients with morbid obesity: outcome after bariatric surgery. Obes Surg 2004;14:1381–1388.
18.
Lankford DA, Proctor CD, Richard R: Continuous positive airway pressure (CPAP) changes in bariatric surgery patients undergoing rapid weight loss. Obes Surg 2005;15:336–341.
19.
Charuzi I, Fraser D, Peiser J, Ovnat A, Lavie P: Sleep apnea syndrome in the morbidly obese undergoing bariatric surgery. Gastroenterol Clin North Am 1987;16:517–519.
20.
Dixon JB, Schachter LM, O’Brien PE: Polysomnography before and after weight loss in obese patients with severe sleep apnea. Int J Obes 2005;29:1048–1054.
21.
Sugerman HJ, Fairman RP, Sood RK, Engle K, Wolfe L, Kellum JM: Long-term effects of gastric surgery for treating respiratory insufficiency of obesity. Am J Clin Nutr 1992;55:s597–s601.
22.
Pillar G, Peled R, Lavie P: Recurrence of sleep apnea without concomitant weight increase 7.5 years after weight reduction surgery. Chest 1994;106:1702–1704.
23.
Charuzi I, Ovnat A, Peiser J, Saltz H, Lavie P: The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome. Surgery 1985;97:535–538.
24.
Valencia-Flores M, Orea A, Herrera M, Santiago V, Rebollar V, Castano VA, Osequera J, Pedroza J, Sumano J, Resendiz M, Garcia-Ramos G: Effect of bariatric surgery on obstructive sleep apnea and hypopnea syndrome, electrocardiogram, and pulmonary arterial pressure. Obes Surg 2004;14:755–762.
25.
Scheuller M, Weider D: Bariatric surgery for treatment of sleep apnea syndrome in 15 morbidly obese patients: long-term results. Otolaryngol Head Neck Surg 2001;125:299–302.
26.
Guardiano SA, Scott JA, Ware JC, Schechner SA: The long-term results of gastric bypass on indexes of sleep apnea. Chest 2003;124:1615–1619.
27.
Fritscher LG, Mottin CC, Canani S, Chatkin JM: Obesity and obstructive sleep apnea-hypopnea syndrome: the impact of bariatric surgery. Obes Surg 2007;17:95–99.
28.
Capella JF, Capella RF: The weight reduction operation of choice. Am J Surg 1996;171:74–79.
29.
Fobi MAL: The Surgical technique of the Fobi pouch operation for obesity. Obes Surg 1998;8:283–288.
30.
Masharani U, Karam JH: Diabetes mellitus and hypoglycemia; in Tierney LM, McPhee SJ, Papadakis MA (eds): Current Medical Diagnosis and Treatment, ed 40. New York, Lange, 2001, pp 1161–207.
31.
Massie BM: Systemic hypertension; in Tierney LM, McPhee SJ, Papadakis MA (eds): Current Medical Diagnosis and Treatment, ed 40. New York, Lange, 2001, pp 448–472.
32.
Baron RB: Lipid Abnormalities; in Tierney LM, McPhee SJ, Papadakis MA (eds): Current Medical Diagnosis and Treatment, Ed 40. New York, Lange, 2001, pp 1208–1221.
33.
Hellmann DB, Stone JH: Arthritis and musculoskeletal disorders; in Tierney LM, McPhee SJ, Papadakis MA (eds): Current Medical Diagnosis and Treatment, ed 40. New York, Lange, 2001, pp 814–868.
34.
Rechtschaffen A, Kales A: A Manual of Standardized Terminology, Techniques, and Scoring System for Sleep Stages in Human Subjects. Los Angeles, Brain Information Service, 1968.
35.
Sleep Disorders Task Force: EEG arousals: scoring rules and examples: a preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 1992;15:173–184.
36.
American Academy of Sleep Medicine Task Force: A report. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 1999;22:667–689.
37.
Johns MW: A new method of measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540–545.
38.
Johns MW: Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep 1992;15:376–381.
39.
Deitel M, Greenstein RJ: Recommendations for reporting weight loss. Obes Surg 2003;13:159–160.
40.
McNicholas WY, Ryan S: Obstructive sleep apnoea syndrome: translating science to clinical practice. Respirology 2006;11:136–144.
41.
Ryan S, Taylor CT, McNicholas WY: Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660–2667.
42.
Oflaz H, Cuhadaroglu C, Pamukcu B, Meric M, Ece T, Kasikcioglu E, Koylan N: Endothelial function in patients with obstructive sleep apnea syndrome but without hypertension. Respiration 2006;73:751–756.
43.
Dincer HE, O’Neill W: Deleterious effects of sleep-disordered breathing on the heart and vascular system. Respiration 2006;73:124–130.
44.
Boudjeltia KZ, Meerhaeghe AV, Doumit S, Guillaume M, Cauchie P, Brohee D, Vanhaeverbeek M, Kerkhofs M: Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration 2006;73:243–246.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.